Deignan Charles A. has filed 8 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 200000 shares of Clearside Biomedical, Inc. ($CLSDQ) on January 08, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2025 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | S | Common Stock | 12900 | $1.28 | 384,662.0000 | 0 | 3.24% | 0.00% |
| Jan. 18, 2024 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 18, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 13, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | M | Common Stock | 34090 | $0.40 | 397,562.0000 | 0 | 9.38% | 0.00% |
| Sept. 13, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | M | Employee Stock Option (right to buy) | 34090 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 19, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | S | Common Stock | 14030 | $1.50 | 363,472.0000 | 0 | 3.72% | 0.00% |
| Jan. 4, 2023 | Clearside Biomedical, Inc. | $CLSDQ | Deignan Charles A. | Chief Financial Officer | A | Employee Stock Option (right to buy) | 187500 | $0.00 | 187,500.0000 | 0 | 9999.99% | 0.00% |